These include the induction of apoptosis, inhibition of tumor proliferation, and modulation of key oncogenic signaling pathways, such as nuclear factor-kappa B (NF-κB) and the protein kinase B/mammalian target of rapamycin (Akt/mTOR) axis [10,23,24,25,26]. This evidence concerns the gene MTOR and neoplasm.